Alnylam ALNY

Latest articles

27d
Market Watch
Alnylam shares surge 40% on drug results that may herald a new type of medicinePhase 3 results for an RNAi therapeutic, marking the potential arrival of an en
Market Watch / Posted 27 days ago
Phase 3 results for an RNAi therapeutic, marking the potential arrival of an entirely new class of medicines,” said Alnylam ALNY, +40.09% Chief Executive John Maraganore. RNAi is a gene silencing technique that drugmakers have long thought... Read more

In this news